Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Arch Toxicol. 2019 Apr 21;93(6):1665–1677. doi: 10.1007/s00204-019-02449-y

Figure 4.

Figure 4.

Effect of TBT exposure on mRNA (ABCA1 and StAR; A) and protein (ABCA1; B) expression (mean ± SEM) in pre-luteinized ovine primary theca cells exposed to 1 ng/ml TBT (gray bars), 10 ng/ml TBT (closed bars) and / or RXR antagonist (UVI3003; 0.05, 2, 4 and 8 μM) or vehicle (control group; open bars). Asterisks denote differences among treatments (P < 0.05). N=3 primary cultured cell lines per group.